Additionally, a high level of S100A7 was correlated with poor OS, first progression (FP), and PPS prognosis for lung cancer (Figure S7B) and gastric cancer (Figure S7C), as well as a poor OS and disease-specific survival (DSS) for liver cancer (Figure S7E) but not ovarian cancer (Figure S7D). Here, S100A7 is linked to lung cancer.